General Statement of Disclosure:

CONSULTING FEES/HONORARIA: United Therapeutics(MODEST), Boston Scientific(SIGNIFICANT), Liquidia(MODEST), NXT(MODEST), Altevant(MODEST), Aerovate Therapeutics(MODEST), Actelion/Janssen/J&J(SIGNIFICANT), Pulnovo Medical Inc(SIGNIFICANT), Natera(MODEST), Janssen (SIGNIFICANT), Keros(MODEST), Kamada(MODEST), Tectonic Therapeutics(MODEST) RESEARCH/RESEARCH GRANTS: Acceleron/Merck(SIGNIFICANT)

View Full Disclosure